Skip to content

Drug interactions

Eslicarbazepine + Metformin-pioglitazone

Severity: Minor

Eslicarbazepine and Metformin-pioglitazone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eslicarbazepine is a weak CYP3A4 inducer and may slightly reduce pioglitazone exposure. Clinical consequences are expected to be limited, though glycemic control may be somewhat less effective.

What this interaction means in plain words

Eslicarbazepine and Metformin-pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Eslicarbazepine belongs to Central Nervous System; Metformin-pioglitazone belongs to Endocrine.

Evidence level: Low

Why it happens

Weak induction of CYP3A4 by eslicarbazepine may increase pioglitazone clearance.

What to do

Monitor glucose control when eslicarbazepine is started or stopped; adjust pioglitazone only if control changes.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eslicarbazepine and Metformin-pioglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Eslicarbazepine with Metformin-pioglitazone?

MediHelp rates the interaction as minor. Eslicarbazepine and Metformin-pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Eslicarbazepine is a weak CYP3A4 inducer and may slightly reduce pioglitazone exposure. Clinical consequences are expected to be limited, though glycemic control may be somewhat less effective.

How serious is the interaction between Eslicarbazepine and Metformin-pioglitazone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor glucose control when eslicarbazepine is started or stopped; adjust pioglitazone only if control changes.

What other medicines interact with Metformin-pioglitazone?

MediHelp also lists interactions of Metformin-pioglitazone with, for example, Contrast media, Diatrizoate meglumine / diatrizoate, Diatrizoate. The full list is on the Metformin-pioglitazone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in